1. Home
  2. LXRX vs CODI Comparison

LXRX vs CODI Comparison

Compare LXRX & CODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • CODI
  • Stock Information
  • Founded
  • LXRX 1995
  • CODI 2005
  • Country
  • LXRX United States
  • CODI United States
  • Employees
  • LXRX N/A
  • CODI N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • CODI Home Furnishings
  • Sector
  • LXRX Health Care
  • CODI Consumer Discretionary
  • Exchange
  • LXRX Nasdaq
  • CODI Nasdaq
  • Market Cap
  • LXRX 552.4M
  • CODI 480.0M
  • IPO Year
  • LXRX 2000
  • CODI 2006
  • Fundamental
  • Price
  • LXRX $1.38
  • CODI $6.38
  • Analyst Decision
  • LXRX Buy
  • CODI Buy
  • Analyst Count
  • LXRX 5
  • CODI 2
  • Target Price
  • LXRX $3.23
  • CODI $26.00
  • AVG Volume (30 Days)
  • LXRX 2.4M
  • CODI 2.6M
  • Earning Date
  • LXRX 11-06-2025
  • CODI 10-29-2025
  • Dividend Yield
  • LXRX N/A
  • CODI 15.67%
  • EPS Growth
  • LXRX N/A
  • CODI N/A
  • EPS
  • LXRX N/A
  • CODI N/A
  • Revenue
  • LXRX $58,432,000.00
  • CODI $2,198,233,000.00
  • Revenue This Year
  • LXRX $66.55
  • CODI $15.09
  • Revenue Next Year
  • LXRX N/A
  • CODI $8.26
  • P/E Ratio
  • LXRX N/A
  • CODI N/A
  • Revenue Growth
  • LXRX 1504.83
  • CODI 11.87
  • 52 Week Low
  • LXRX $0.28
  • CODI $5.98
  • 52 Week High
  • LXRX $1.95
  • CODI $24.32
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 49.80
  • CODI 39.30
  • Support Level
  • LXRX $1.30
  • CODI $7.22
  • Resistance Level
  • LXRX $1.48
  • CODI $8.07
  • Average True Range (ATR)
  • LXRX 0.07
  • CODI 0.58
  • MACD
  • LXRX -0.02
  • CODI -0.17
  • Stochastic Oscillator
  • LXRX 27.77
  • CODI 7.94

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About CODI D/B/A Compass Diversified Holdings Shares of Beneficial Interest

Compass Diversified Holdings is a diversified business conglomerate based in the United States having two groups: branded consumer business and industrial business. Branded consumer businesses are characterized as those businesses that capitalize on a valuable brand name in their respective market sector. It includes 5.11, Ergobaby, Liberty Safe, and Velocity Outdoor. Industrial businesses are characterized as those businesses that focus on manufacturing and selling particular products and industrial services within a specific market sector. The company has operations in the United States, Canada, Europe, Asia Pacific, and other International areas.

Share on Social Networks: